Bellevue Asset Management’s Privia Health PRVA Stock Holding History

Bellevue Asset Management’s Portfolio PRVA Stock Details PRVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-146	Closed	-$3.46K	–	468
2025 Q4	$3.46K	Hold	146	–	–	﹤0.01%	379
2025 Q3	$3.63K	Buy	146 +40	+38%	+$861	﹤0.01%	375
2025 Q2	$2.44K	Hold	106	–	–	﹤0.01%	413
2025 Q1	$2.38K	Hold	106	–	–	﹤0.01%	411
2024 Q4	$2.07K	Hold	106	–	–	﹤0.01%	437
2024 Q3	$1.93K	Hold	106	–	–	﹤0.01%	417
2024 Q2	$1.84K	Hold	106	–	–	﹤0.01%	417
2024 Q1	$2.08K	Hold	106	–	–	﹤0.01%	405
2023 Q4	$2.44K	Hold	106	–	–	﹤0.01%	385
2023 Q3	$2.44K	Buy	106 +19	+22%	+$483	﹤0.01%	363
2023 Q2	$2.27K	Hold	87	–	–	﹤0.01%	391
2023 Q1	$2.4K	Buy	87 +24	+38%	+$634	﹤0.01%	391
2022 Q4	$1.41K	Hold	63	–	–	﹤0.01%	443
2022 Q3	$2K	Hold	63	–	–	﹤0.01%	425
2022 Q2	$2K	Sell	63 -15	-19%	-$381	﹤0.01%	427
2022 Q1	$2K	Buy	78 +16	+26%	+$378	﹤0.01%	470
2021 Q4	$2K	Sell	62 -5	-7%	-$125	﹤0.01%	510
2021 Q3	$2K	Buy	+67	New	+$2.34K	﹤0.01%	536

Other funds holding PRVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Bellevue Asset Management's PRVA Position: Q1 2026 in Review

Bellevue Asset Management sold out of Privia Health (PRVA) in Q1 2026, closing a stake of 146 shares — an estimated $3.46K sold.

Bellevue Asset Management first reported a position in PRVA in Q3 2021 and held it in 18 quarters. The position peaked at $3.63K in Q3 2025. 293 funds tracked by Wall St. Rank hold PRVA as of Q1 2026.

Bellevue Asset Management reported no remaining Privia Health position as of Q1 2026 after selling out during the quarter.
Bellevue Asset Management sold 146 Privia Health shares in Q1 2026, an estimated $3.46K.
Bellevue Asset Management first reported a position in Privia Health in Q3 2021 and held it in 18 quarters.
Bellevue Asset Management's Privia Health position peaked at $3.63K in Q3 2025.
293 funds tracked by Wall St. Rank held Privia Health as of Q1 2026.

Based on Bellevue Asset Management's 13F filing for Q1 2026, filed 24 Apr 2026.